Childhood T-Cell Acute Lymphoblastic Leukemia: The Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Experience
Top Cited Papers
- 1 October 2003
- journal article
- pediatric oncology
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (19) , 3616-3622
- https://doi.org/10.1200/jco.2003.10.116
Abstract
Purpose: T-cell acute lymphoblastic leukemia (T-ALL) accounts for 10% to 15% of newly diagnosed cases of childhood acute lymphoblastic leukemia (ALL). Historically, T-ALL patients have had a worse ...Keywords
This publication has 25 references indexed in Scilit:
- Treatment of Childhood Acute Lymphoblastic Leukemia: Results of Dana-Farber ALL Consortium Protocol 87-01Journal of Clinical Oncology, 2002
- Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01Blood, 2001
- Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981–1995)Leukemia, 2000
- Induction failure in acute lymphoblastic leukemia of childhoodCancer, 1999
- Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.Journal of Clinical Oncology, 1994
- Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update)Blood, 1991
- Four-Agent Induction and Intensive Asparaginase Therapy for Treatment of Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1986
- T-Cell Acute Lymphoblastic Leukemia in ChildrenPublished by Springer Nature ,1981
- Clinical Importance of Lymphoblasts with T Markers in Childhood Acute LeukemiaNew England Journal of Medicine, 1975
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958